ClinicalTrials.Veeva

Menu
V

Veritus Research | Melbourne, Australia.

Research site
(Unclaimed)

Site insights

Top conditions

Top treatments

SHR-2173
APL-10456
EQ504
SNS851
ZB002

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

5 of 8 total trials

A Phase I, Randomized, Double-Blind, Placebo-Controlled Study of EQ504 in Single and Multiple Ascending Doses in Healthy Volunteers

This is a Phase 1, first in human, three-part randomized, double-blind, placebo-controlled dose escalation trial to evaluate the safety, tolerability...

Not yet enrolling
Ulcerative Colitis
Drug: EQ504
Drug: EQ504 Placebo

AP09CP01 is a Phase 1, Randomized, Double-Blind, Placebo-Controlled, Two-Part Study which is conducted in Australia. The main purpose of this researc...

Active, not recruiting
Rhinovirus
Drug: APL-10456-Vaccine
Other: Placebo

This study is a Phase1, randomized, double-blinded, and placebo-controlled study. In each cohort, enrolled participants will be randomized to receive...

Enrolling
Overweight or Obese
Drug: Subcutaneous single and mutiple dose
Drug: Placebo

This is a Phase I, randomized, double-blind study designed to evaluate the safety, tolerability, and pharmacokinetics of subcutaneous administration...

Enrolling
Metabolic Disease
Drug: SNS851
Other: Placebo

This study is being done to find out how safe and effective a new combined vaccine candidate, called VXB-251, is for older adults. The vaccine candid...

Active, not recruiting
Healthy Participants
Lower Respiratory Tract Disease
Biological: trivalent (RSV/hMPV/PIV3) vaccine candidate
Biological: monovalent (PIV3) unlicensed comparator

Trial sponsors

A
Arcturus Therapeutics logo
A
E
O
Sanofi logo
Z
S

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems